"U.S. stocks edged lower on Tuesday as weakness in the energy and financial sectors outweighed gains in technology shares.
Keep Reading →
May 30 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...
Keep Reading →
April 15 - Hedge Funds
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
Keep Reading →
April 12 - Lists, News
The 10 least obese countries in the world are mostly from Asia and Africa.
Keep Reading →
March 26 - Lists, News
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
Keep Reading →
March 15 - Lists, News
Most HIV patients have no options in regard to how they must consume their medication.
Keep Reading →
February 14 - News, Stock Analysis
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S. Food and Drug Administration.
Keep Reading →
February 2 - News, Stock Analysis
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Keep Reading →
January 26 - Lists, News
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News
NeRRe Therapeutics, which is a GlaxoSmithKline PLC (ADR) (NYSE:GSK) spinout, has raised £23 million ($28 million) in a Series B financing round.
Keep Reading →
January 6 - News, Stock Analysis
It takes a lot of guts for an individual to stand up against huge corporate entities for the overall well-being of the society.
Keep Reading →
December 30 - Lists, News
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.
Keep Reading →
December 21 - News, Stock Analysis
The National Institute for Health and Care Excellence (NICE) has confirmed the approval of a new injectable asthma drug from GlaxoSmithKline PLC (ADR) (NYSE:GSK).
Keep Reading →
December 2 - News, Stock Analysis
GlaxoSmithKline plc (ADR) (NYSE:GSK) has moved to expand the target market for its blockbuster vaccine, Shingrix, with the filing of a regulatory application in Europe.
Keep Reading →
November 30 - News, Stock Analysis
Theravance Biopharma Inc (NASDAQ:TBPH) just put out an announcement relating to its closed triple asset, and the company is trading flat-to-down despite the seemingly positive...
Keep Reading →
November 22 - News, Stock Analysis
No stock is ever a sure thing, but that doesn’t mean you can’t get asymptotically close to one. Following the announcement by VBI Vaccines, Inc.
Keep Reading →
November 14 - News, Stock Analysis
The US Food and Drug Administration (FDA) has recently cleared the Propeller platform of Propeller Health for use with GlaxoSmithKline Plc (ADR) (NYSE:GSK)'s Ellipta dry powder...
Keep Reading →
November 8 - News, Stock Analysis
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News
GlaxoSmithKline plc (ADR) (NYSE:GSK) (GSK) has recently entered into a collaborative agreement with Fimbrion Therapeutics, Inc.
Keep Reading →
October 26 - News, Stock Analysis
GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question the motive behind its...
Keep Reading →
October 19 - News, Stock Analysis
Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit...
Keep Reading →
September 20 - News, Stock Analysis
Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process...
Keep Reading →
August 29 - News, Stock Analysis
Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in...
Keep Reading →
August 1 - Earnings Report, News, Tech
The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp...
Keep Reading →
July 18 - Market Movers, News
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.
Keep Reading →
June 13 - Hedge Fund Analysis, Hedge Funds
GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated...
Keep Reading →
June 9 - News, Stock Analysis
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients...
Keep Reading →
June 8 - News, Stock Analysis
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Keep Reading →
June 8 - News, Stock Analysis
Deerfield Management, a healthcare-focused fund managed by James E.
Keep Reading →
December 11 - Hedge Funds, News
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Keep Reading →
November 27 - Hedge Funds, News
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
Keep Reading →
June 27 - Lists
Hedge funds have started submitting their 13F filings with the SEC, offering other investors a chance to look at their equity holdings as of the end of the first quarter.
Keep Reading →
April 24 - Hedge Funds, News
GlaxoSmithKline plc (ADR) (NYSE:GSK) remains committed to eradicating the deadly virus which has already claimed more than 2,000 lives in Western Africa and is considered as the...
Keep Reading →
September 8 - News
Companies around the world, who do business in China were keeping a close watch on the trial of the British company investigator, Peter Humphrey, and his American wife and...
Keep Reading →
August 10 - News
In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr.
Keep Reading →
July 18 - Earnings Report, News
Rio Tinto plc (ADR) (NYSE:RIO), the world’s second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.
Keep Reading →
July 17 - News
Warren Buffett’s Berkshire Hathaway, in its latest 13F, revealed its equity portfolio held at the end of the fourth quarter of 2013.
Keep Reading →
February 14 - Hedge Funds, News
Relvar Ellipta: Over the past few days, research-based pharmaceutical GlaxoSmithKline plc (ADR) (NYSE:GSK) and biopharmaceutical company Theravance Inc (NASDAQ:THRX)’s Relvar...
Keep Reading →
September 23 - News
To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.
Keep Reading →
September 23 - News
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Keep Reading →
September 23 - News
There is perhaps nothing scarier than a cancer diagnosis.
Keep Reading →
September 17 - News
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Keep Reading →
September 17 - News
There's no question that America is addicted to caffeine and sugar.
Keep Reading →
September 17 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
Keep Reading →
September 16 - News
There are plenty of biotech companies that put all of their eggs in one basket these days.
Keep Reading →
September 16 - News
Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.
Keep Reading →
September 16 - News
In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they're hot like summer, sometimes they're dormant and cold like winter.
Keep Reading →
September 16 - News
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
September 15 - News
There hasn't been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before the Food and Drug Administration...
Keep Reading →
September 12 - News